July 19, 2016
Perrigo Co. PLC has again come under fire for allegedly misleading stockholders to spurn fellow generic drug maker Mylan NV's $35.6 billion hostile takeover attempt, after a Perrigo investor brought a proposed class action in a New Jersey federal court on Monday.